Sudden cardiac death, altitude & physical activity: A retrospective analysis from the highest Italian region (Aosta valley)
Legal Medicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 102608 - 102608
Published: March 1, 2025
Language: Английский
VEGF Polymorphisms (VEGF-936 C/T, VEGF-634 G/C and VEGF-2578 C/A) and Cardiovascular Implications in Long COVID Patients
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(16), P. 8667 - 8667
Published: Aug. 8, 2024
The
COVID-19
pandemic
has
raised
awareness
of
the
virus’s
long-term
non-pulmonary
consequences.
This
study
examined
relationship
between
genetic
polymorphisms
VEGF
and
cardiac
dysfunction
subclinical
atherosclerosis
in
patients
recovering
from
COVID-19.
included
67
previously
diagnosed
with
VEGF-936C/T,
VEGF-634G/C,
VEGF-2578C/A
statuses
were
determined.
Conventional
echocardiography
arterial
parameters
assessments
performed
at
inclusion
six
months
after
first
assessment.
For
dominant
over-dominant
models
showed
a
significant
increase
ejection
fraction
COVID
(p
=
0.044
0.048)
was
also
predictive
independent
factor
for
augmentation
index
(β
3.07;
p
0.024).
model
rise
RV-RA
gradient
(3.702
mmHg)
0.028
95%
CI:
0.040–7.363),
indicating
greater
difference
(4.254
0.025
0.624–7.884).
findings
VEGF-634G/C
not
statistically
significant,
except
TAPSE
during
initial
evaluation,
using
codominant
model.
VEGF-2578C/A,
ventricular
filling
pressure
(E/E’ratio)
best
described
under
recessive
Our
research
suggests
that
VEG-936C/T
genotype
may
impact
baseline
level
subsequent
changes
function
atherosclerosis.
These
offer
valuable
insights
into
complex
correlation
cardiovascular
disfunction
long
patients.
Language: Английский
Epithelial Antimicrobial Peptide/Protein and Cytokine Expression Profiles Obtained from Nasopharyngeal Swabs of SARS-CoV-2-Infected and Non-Infected Subjects
Thilo Gambichler,
No information about this author
Silke Goesmann,
No information about this author
Marina Skrygan
No information about this author
et al.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(9), P. 1471 - 1471
Published: Sept. 15, 2024
Immune
responses
of
the
epithelia
upper
respiratory
tract
are
likely
crucial
in
early
inhibition
viral
replication
and
finally
clearance
SARS-CoV-2.
We
aimed
to
compare
expression
profiles
antimicrobial
peptides/proteins
(AMPs)
related
cytokines
observed
nasopharynx
SARS-CoV-2-infected
patients
non-infected
controls
assess
associations
between
these
parameters
COVID-19
patients’
outcomes.
included
45
subjects
who
had
tested
positive
for
SARS-CoV-2
22
control
negative
Biomaterial
detection,
as
well
gene
protein
studies,
was
obtained
from
all
using
nasopharyngeal
swabs
which
were
performed
a
maximum
7
days
before
inclusion
study.
Univariable
multivariable
statistics
performed.
When
compared
controls,
mRNA
levels
human
β-defensin
1
(hBD-1),
LL-37,
trappin-2
significantly
higher
specimens
patients.
Protein
hBD-1
also
increased
group.
interferon-ɣ
(IFN-ɣ),
tumor
necrosis
factor-
ɑ
(TNF-ɑ),
interleukin-6
(IL-6)
measured
than
those
could
be
confirmed
IFN-ɣ
IL-6.
A
significant
correlation
only
analysis
revealed
that
low
associated
with
severe/fatal
The
occurrence
pneumonia
lower
IL-6
mRNA,
TNF-ɑ
mRNA.
Concerning
outcomes,
logistic
regression
model
none
aforementioned
remained
model.
However,
independent
predictor
absence
[odds
ratio:
0.35
(95%
CI
0.14
0.88,
p
=
0.024)].
In
conclusion,
AMPs
(hBD-1,
trappin-2)
(IL-6,
IFN-ɣ,
TNF-ɑ)
is
upregulated
response
infection,
indicating
play
role
local
host
defense
against
virus.
Upregulated
during
phase
infection
pneumonia.
Hence,
high
appears
protective
factor
lung
complications
Language: Английский
Impact of the Coronavirus Disease 2019 [COVID-19] Pandemic on Post-Acute Care of Patients with Heart Failure and the Effectiveness of Vaccine Prevention
Ling-Yu Chang,
No information about this author
Chin-Yi Chao,
No information about this author
Jin‐Long Huang
No information about this author
et al.
Healthcare,
Journal Year:
2024,
Volume and Issue:
12(21), P. 2171 - 2171
Published: Oct. 31, 2024
The
Heart
Failure
Post-Acute
Care
[HF-PAC]
program
is
a
specialized
healthcare
aimed
at
providing
comprehensive
care
and
support
for
patients
with
heart
failure
[HF]
as
they
transition
from
acute
hospital
settings
to
home.
But
the
impact
of
coronavirus
disease
2019
[COVID-19]
pandemic
on
HF-PAC
remains
unknown.
Furthermore,
effects
COVID-19
vaccination
these
warrants
further
investigation.
Language: Английский